[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Chan Zuckerberg Initiative Single-Cell COVID-19 Consortia et al., 2020 - Google Patents

Single cell profiling of COVID-19 patients: an international data resource from multiple tissues

Chan Zuckerberg Initiative Single-Cell COVID-19 Consortia et al., 2020

View PDF
Document ID
12053927834010429378
Author
Chan Zuckerberg Initiative Single-Cell COVID-19 Consortia
Ballestar E
Farber D
Glover S
Horwitz B
Meyer K
Nikolić M
Ordovas-Montanes J
Sims P
Shalek A
Vandamme N
Vandekerckhove L
Vento-Tormo R
Villani A
Publication year
Publication venue
MedRxiv

External Links

Snippet

In late 2019 and through 2020, the COVID-19 pandemic swept the world, presenting both scientific and medical challenges associated with understanding and treating a previously unknown disease. To help address the need for great understanding of COVID-19, the …
Continue reading at www.medrxiv.org (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriphage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses

Similar Documents

Publication Publication Date Title
Chan Zuckerberg Initiative Single-Cell COVID-19 Consortia et al. Single cell profiling of COVID-19 patients: an international data resource from multiple tissues
Chua et al. COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis
Zhang et al. Single-cell landscape of immunological responses in patients with COVID-19
Bost et al. Host-viral infection maps reveal signatures of severe COVID-19 patients
Yoshida et al. Local and systemic responses to SARS-CoV-2 infection in children and adults
Zhu et al. Single-cell sequencing of peripheral mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients
Liao et al. The landscape of lung bronchoalveolar immune cells in COVID-19 revealed by single-cell RNA sequencing
Lin et al. Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response
Li et al. Whole‐transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID‐19 patients
Giobbe et al. SARS-CoV-2 infection and replication in human gastric organoids
Faure et al. Distinct immune response in two MERS-CoV-infected patients: can we go from bench to bedside?
Pech et al. Rhinovirus infections change DNA methylation and mRNA expression in children with asthma
Zhao et al. Single-cell immune profiling reveals distinct immune response in asymptomatic COVID-19 patients
Delorey et al. A single-cell and spatial atlas of autopsy tissues reveals pathology and cellular targets of SARS-CoV-2
Abdelsattar et al. ACE2 and TMPRSS2 SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection
Andrikovics et al. Current trends in applications of circulatory microchimerism detection in transplantation
Tsalik et al. The host response to viral infections reveals common and virus-specific signatures in the peripheral blood
Gerrard et al. Transcriptomic signatures of Tacaribe virus-infected Jamaican fruit bats
Martin-Sanchez et al. Immunological biomarkers of fatal COVID-19: a study of 868 patients
Upadhyay et al. TREM2+ and interstitial-like macrophages orchestrate airway inflammation in SARS-CoV-2 infection in rhesus macaques
Firoozi et al. Hsa_circ_0000479/Hsa‐miR‐149‐5p/RIG‐I, IL‐6 Axis: a potential novel pathway to regulate immune response against COVID‐19
Xiong et al. Cytotoxic CD161− CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus
Ilieva et al. The current status of gene expression profilings in COVID‐19 patients
Subramaniyan et al. Characterization of the SARS-CoV-2 host response in primary human airway epithelial cells from aged individuals
Aevermann et al. Machine learning-based single cell and integrative analysis reveals that baseline mDC predisposition correlates with hepatitis B vaccine antibody response